A recent study showed that RON is increasingly expressed during progression of pancreatic cancer (68) and that RON shows sustained expression in pancreatic cancer stem cells [69] suggesting its potential value as a therapeutic target for this disease. The gene discussed is MST1R; the disease is familial pancreatic carcinoma.